Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04607408
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2020-10-16
Brief Title:
Evaluating Safety and Immune Response to the HIV-1 CH505 TransmittedFounder gp120 Adjuvanted With GLA-SE in Healthy HIV-exposed Uninfected Infants
Sponsor:
Organization:
HIV Vaccine Trials Network
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
38
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: